J-GLOBAL ID:200901013681848625   Update date: Oct. 01, 2021

Aizaki Yoshimi

Aizaki Yoshimi
Affiliation and department:
Research theme for competitive and other funds  (1):
  • 2009 - 2011 ACE阻害薬の降圧を超えた新たな薬効メカニズム:ACEシグナリングの新展開
Papers (13):
  • Yokota K, Sato K, Miyazaki T, Aizaki Y, Tanaka S, Sekikawa M, Kozu N, Kadono Y, Oda H, Mimura T. Characterization and Function of Tumor Necrosis Factor alpha and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis. Arthritis & Rheumatology. 2021. 73. 7. 1145-1154
  • Aizaki Y, Yazawa H, Sato K, Mimura T. Dual effects of interleukin 10 on natural killer cells and monocytes and the implications for adult-onset Still’s disease. Clinical & Experimental Rheumatology. 2021
  • Asanuma YF, Aizaki Y, Noma H, Yokota K, Matsuda M, Kozu N, Takebayashi Y, Nakatani H, Hasunuma T, Kawai S, et al. Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study. Modern Rheumatology. 2019. in press. in press
  • Yasuto Araki, Yoshimi Aizaki, Kojiro Sato, Hiromi Oda, Riki Kurokawa, Toshihide Mimura. Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts. Clinical and Experimental Rheumatology. 2018. 36. 2. 314-316
  • Araki Y, Wada T, Aizaki Y, Sato K, Yokota K, Fujimoto K, Kim Y, Oda H, Kurokawa R, Mimura T. Histone methylation and STAT3 differentially regulate IL-6-induced MMP gene activation in rheumatoid arthritis synovial fibroblasts. Arthritis & Rheumatology. 2016. 68. 5. 1111-1123
Patents (1):
  • ベーチェット病の判定を補助する方法、及びベーチェット病の活動性の評価を補助する方法
Books (2):
  • MR薬理学
    恒心社出版 2010
  • 「MR薬理学」
    恒心社出版 2010
Association Membership(s) (1):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page